SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 9, 2015, Pages 1950-1959

  Almeida, Bruno ^a,b   Abreu, Isabel A ^a,b,g   Matos, Carlos A ^c,d   Fraga, Joana S ^a,b   Fernandes, Sara ^a,b   Macedo, Maria G ^a,b   Gutiérrez Gallego, Ricardo ^e,f   Pereira, Pedro José Barbosa ^a,b   Carvalho, Ana Luísa ^c,d   Macedo Ribeiro, Sandra ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e HOSPITAL DEL MAR   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

Amyloid; Polyglutamine; Posttranslational modification; Protein aggregation; Surface plasmon resonance

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID; ATAXIN 3; LYSINE; POLYGLUTAMINE; PROTEIN P97; SUMO 1 PROTEIN; SUMO 2 PROTEIN; UBIQUITIN;

ANIMAL CELL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BRAIN CELL; BRAIN CELL CULTURE; CELL LYSATE; CIRCULAR DICHROISM; CONTROLLED STUDY; COS 7 CELL LINE; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; OLIGOMERIZATION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; SUMOYLATION; SURFACE PLASMON RESONANCE; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84955513053     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.06.010     Document Type: Article

References (66)

1. Matos C.A., de Macedo-Ribeiro S., Carvalho A.L. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Prog. Neurobiol. 2011, 95:26-48.
2. Macedo-Ribeiro S., Cortes L., Maciel P., Carvalho A.L. Nucleocytoplasmic shuttling activity of ataxin-3. PLoS One 2009, 4:e5834.
3. Antony P.M., Mantele S., Mollenkopf P., Boy J., Kehlenbach R.H., Riess O., Schmidt T. Identification and functional dissection of localization signals within ataxin-3. Neurobiol. Dis. 2009, 36:280-292.
4. Perez M.K., Paulson H.L., Pittman R.N. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum. Mol. Genet. 1999, 8:2377-2385.
5. Burnett B., Li F., Pittman R.N. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 2003, 12:3195-3205.
6. Doss-Pepe E.W., Stenroos E.S., Johnson W.G., Madura K. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol. Cell. Biol. 2003, 23:6469-6483.
7. Zhong X., Pittman R.N. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum. Mol. Genet. 2006, 15:2409-2420.
8. Evert B.O., Araujo J., Vieira-Saecker A.M., de Vos R.A., Harendza S., Klockgether T., Wullner U. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J. Neurosci. 2006, 26:11474-11486.
9. Rodrigues A.J., do Carmo Costa M., Silva T.L., Ferreira D., Bajanca F., Logarinho E., Maciel P. Absence of ataxin-3 leads to cytoskeletal disorganization and increased cell death. Biochim. Biophys. Acta 2010, 1803:1154-1163.
10. do Carmo Costa M., Bajanca F., Rodrigues A.J., Tome R.J., Corthals G., Macedo-Ribeiro S., Paulson H.L., Logarinho E., Maciel P. Ataxin-3 plays a role in mouse myogenic differentiation through regulation of integrin subunit levels. PLoS One 2010, 5:e11728.
11. Bevivino A.E., Loll P.J. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta-fibrils. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:11955-11960.
12. Marchal S., Shehi E., Harricane M.C., Fusi P., Heitz F., Tortora P., Lange R. Structural instability and fibrillar aggregation of non-expanded human ataxin-3 revealed under high pressure and temperature. J. Biol. Chem. 2003, 278:31554-31563.
13. Chow M.K., Paulson H.L., Bottomley S.P. Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease. J. Mol. Biol. 2004, 335:333-341.
14. Masino L., Nicastro G., Menon R.P., Dal Piaz F., Calder L., Pastore A. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J. Mol. Biol. 2004, 344:1021-1035.
15. Gales L., Cortes L., Almeida C., Melo C.V., Costa M.C., Maciel P., Clarke D.T., Damas A.M., Macedo-Ribeiro S. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. J. Mol. Biol. 2005, 353:642-654.
16. Robertson A.L., Bottomley S.P. Towards the treatment of polyglutamine diseases: the modulatory role of protein context. Curr. Med. Chem. 2010, 17:3058-3068.
17. Almeida B., Fernandes S., Abreu I.A., Macedo-Ribeiro S. Trinucleotide repeats: a structural perspective. Front. Neurol. 2013, 4:76.
18. Pastore A., Temussi P.A. The two faces of Janus: functional interactions and protein aggregation. Curr. Opin. Struct. Biol. 2012, 22:30-37.
19. Orr H.T. Cell biology of spinocerebellar ataxia. J. Cell Biol. 2012, 197:167-177.
20. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
21. Schaefer M.H., Wanker E.E., Andrade-Navarro M.A. Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks. Nucleic Acids Res. 2012, 40:4273-4287.
22. Todi S.V., Scaglione K.M., Blount J.R., Basrur V., Conlon K.P., Pastore A., Elenitoba-Johnson K., Paulson H.L. Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117. J. Biol. Chem. 2010, 285:39303-39313.
23. Pennuto M., Palazzolo I., Poletti A. Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity. Hum. Mol. Genet. 2009, 18:R40-R47.
24. Todi S.V., Winborn B.J., Scaglione K.M., Blount J.R., Travis S.M., Paulson H.L. Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J. 2009, 28:372-382.
25. Steffan J.S., Agrawal N., Pallos J., Rockabrand E., Trotman L.C., Slepko N., Illes K., Lukacsovich T., Zhu Y.Z., Cattaneo E., Pandolfi P.P., Thompson L.M., Marsh J.L. SUMO modification of Huntingtin and Huntington's disease pathology. Science 2004, 304:100-104.
26. Riley B.E., Zoghbi H.Y., Orr H.T. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal. J. Biol. Chem. 2005, 280:21942-21948.
27. Janer A., Werner A., Takahashi-Fujigasaki J., Daret A., Fujigasaki H., Takada K., Duyckaerts C., Brice A., Dejean A., Sittler A. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. Hum. Mol. Genet. 2010, 19:181-195.
28. Ryu J., Cho S., Park B.C., Lee do H. Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: Implication of JNK pathway. Biochem. Biophys. Res. Commun. 2010, 393:280-285.
29. Mukherjee S., Thomas M., Dadgar N., Lieberman A.P., Iniguez-Lluhi J.A. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J. Biol. Chem. 2009, 284:21296-21306.
30. Scarff C.A., Sicorello A., Tomé R.J.L., Macedo-Ribeiro S., Ashcroft A.E., Radford S.E. A tale of a tail: structural insights into the conformational properties of the polyglutamine protein ataxin-3. Int. J. Mass Spectrom. 2013, 345-347:63-70.
31. Weeks S.D., Grasty K.C., Hernandez-Cuebas L., Loll P.J. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity. J. Biol. Chem. 2011, 286:4555-4565.
32. Niedenthal R. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS). Methods Mol. Biol. 2009, 497:63-79.
33. Tang W.K., Li D., Li C.C., Esser L., Dai R., Guo L., Xia D. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J. 2010, 29:2217-2229.
34. Ferro A., Carvalho A.L., Teixeira-Castro A., Almeida C., Tome R.J., Cortes L., Rodrigues A.J., Logarinho E., Sequeiros J., Macedo-Ribeiro S., Maciel P. NEDD8: a new ataxin-3 interactor. Biochim. Biophys. Acta 2007, 1773:1619-1627.
35. Hilgarth R.S., Sarge K.D. Analysis of protein sumoylation. Curr Protoc. Protein Sci 2006, 44:14.8:18.8.1-14.8.7.
36. Louros S.R., Hooks B.M., Litvina L., Carvalho A.L., Chen C. A role for stargazin in experience-dependent plasticity. Cell Rep. 2014, 7:1614-1625.
37. Jiang M., Deng L., Chen G. High Ca(2+)-phosphate transfection efficiency enables single neuron gene analysis. Gene Ther. 2004, 11:1303-1311.
38. Sreerama N., Woody R.W. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 2000, 287:252-260.
39. Ellisdon A.M., Thomas B., Bottomley S.P. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J. Biol. Chem. 2006, 281:16888-16896.
40. Harris G.M., Dodelzon K., Gong L., Gonzalez-Alegre P., Paulson H.L. Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties. PLoS One 2010, 5:e13695.
41. Jakobs A., Himstedt F., Funk M., Korn B., Gaestel M., Niedenthal R. Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation. Nucleic Acids Res. 2007, 35:e109.
42. Jakobs A., Koehnke J., Himstedt F., Funk M., Korn B., Gaestel M., Niedenthal R. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat. Methods 2007, 4:245-250.
43. Tatham M.H., Jaffray E., Vaughan O.A., Desterro J.M., Botting C.H., Naismith J.H., Hay R.T. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 2001, 276:35368-35374.
44. Chow M.K., Ellisdon A.M., Cabrita L.D., Bottomley S.P. Purification of polyglutamine proteins. Methods Enzymol. 2006, 413:1-19.
45. Zhou Y.F., Liao S.S., Luo Y.Y., Tang J.G., Wang J.L., Lei L.F., Chi J.W., Du J., Jiang H., Xia K., Tang B.S., Shen L. SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity. PLoS One 2013, 8:e54214.
46. Chow M.K., Ellisdon A.M., Cabrita L.D., Bottomley S.P. Polyglutamine expansion in ataxin-3 does not affect protein stability: implications for misfolding and disease. J. Biol. Chem. 2004, 279:47643-47651.
47. Saunders H.M., Gilis D., Rooman M., Dehouck Y., Robertson A.L., Bottomley S.P. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein. Protein Sci. 2011, 20:1675-1681.
48. Boeddrich A., Gaumer S., Haacke A., Tzvetkov N., Albrecht M., Evert B.O., Muller E.C., Lurz R., Breuer P., Schugardt N., Plassmann S., Xu K., Warrick J.M., Suopanki J., Wullner U., Frank R., Hartl U.F., Bonini N.M., Wanker E.E. An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J. 2006, 25:1547-1558.
49. Kim S.J., Cho J., Song E.J., Kim H.M., Lee K.E., Suh S.W., Kim E.E. Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP). J. Biol. Chem. 2014, 289:12264-12274.
50. Jana N.R., Dikshit P., Goswami A., Kotliarova S., Murata S., Tanaka K., Nukina N. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J. Biol. Chem. 2005, 280:11635-11640.
51. Scaglione K.M., Zavodszky E., Todi S.V., Patury S., Xu P., Rodriguez-Lebron E., Fischer S., Konen J., Djarmati A., Peng J., Gestwicki J.E., Paulson H.L. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol. Cell 2011, 43:599-612.
52. Costa Mdo C., Paulson H.L. Toward understanding Machado-Joseph disease. Prog. Neurobiol. 2012, 97:239-257.
53. Masino L., Nicastro G., Calder L., Vendruscolo M., Pastore A. Functional interactions as a survival strategy against abnormal aggregation. FASEB J. 2011, 25:45-54.
54. Ellisdon A.M., Pearce M.C., Bottomley S.P. Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. J. Mol. Biol. 2007, 368:595-605.
55. Natalello A., Frana A.M., Relini A., Apicella A., Invernizzi G., Casari C., Gliozzi A., Doglia S.M., Tortora P., Regonesi M.E. A major role for side-chain polyglutamine hydrogen bonding in irreversible ataxin-3 aggregation. PLoS One 2011, 6:e18789.
56. Kerscher O. SUMO junction-what's your function?. EMBO Rep. 2007, 8:550-555.
57. Kondo H., Rabouille C., Newman R., Levine T.P., Pappin D., Freemont P., Warren G. p47 is a cofactor for p97-mediated membrane fusion. Nature 1997, 388:75-78.
58. Ye Y., Meyer H.H., Rapoport T.A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 2003, 162:71-84.
59. Dantuma N.P., Hoppe T. Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin. Trends Cell Biol. 2012, 22:483-491.
60. Baek G.H., Cheng H., Choe V., Bao X., Shao J., Luo S., Rao H. Cdc48: a Swiss army knife of cell biology. J. Amino Acids 2013, 2013:183421.
61. Ewens C.A., Kloppsteck P., Forster A., Zhang X., Freemont P.S. Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97. Biochem. Cell Biol. 2010, 88:41-48.
62. Kakizuka A. Roles of VCP in human neurodegenerative disorders. Biochem. Soc. Trans. 2008, 36:105-108.
63. Song J., Durrin L.K., Wilkinson T.A., Krontiris T.G., Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:14373-14378.
64. Song J., Zhang Z., Hu W., Chen Y. Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J. Biol. Chem. 2005, 280:40122-40129.
65. Winborn B.J., Travis S.M., Todi S.V., Scaglione K.M., Xu P., Williams A.J., Cohen R.E., Peng J., Paulson H.L. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J. Biol. Chem. 2008, 283:26436-26443.
66. Hanzelmann P., Buchberger A., Schindelin H. Hierarchical binding of cofactors to the AAA ATPase p97. Structure 2011, 19:833-843.